These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7722290

  • 1. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits.
    Hajishengallis G, Hollingshead SK, Koga T, Russell MW.
    J Immunol; 1995 May 01; 154(9):4322-32. PubMed ID: 7722290
    [Abstract] [Full Text] [Related]

  • 2. Peroral immunization with Helicobacter pylori adhesin protein genetically linked to cholera toxin A2B subunits.
    Kim BO, Shin SS, Yoo YH, Pyo S.
    Clin Sci (Lond); 2001 Mar 01; 100(3):291-8. PubMed ID: 11222115
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR, Hulett K, Pillai SR, Dennis VA, Oh MK, Scissum-Gunn K.
    Vaccine; 2006 Feb 20; 24(8):1213-24. PubMed ID: 16194585
    [Abstract] [Full Text] [Related]

  • 7. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T, Yuki Y, Katakai Y, Shibata H, Tokuhara D, Mejima M, Kurokawa S, Takahashi Y, Nakanishi U, Ono F, Mimuro H, Sasakawa C, Takaiwa F, Terao K, Kiyono H.
    J Immunol; 2009 Nov 15; 183(10):6538-44. PubMed ID: 19880451
    [Abstract] [Full Text] [Related]

  • 8. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.
    Pimenta FC, Miyaji EN, Arêas AP, Oliveira ML, de Andrade AL, Ho PL, Hollingshead SK, Leite LC.
    Infect Immun; 2006 Aug 15; 74(8):4939-44. PubMed ID: 16861686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein.
    Gockel CM, Russell MW.
    Immunology; 2005 Dec 15; 116(4):477-86. PubMed ID: 16313361
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.
    Harakuni T, Sugawa H, Komesu A, Tadano M, Arakawa T.
    Infect Immun; 2005 Sep 15; 73(9):5654-65. PubMed ID: 16113283
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the A2/B subunits of cholera toxin.
    Hajishengallis G, Harokopakis E, Hollingshead SK, Russell MW, Michalek SM.
    Vaccine; 1996 Nov 15; 14(16):1545-8. PubMed ID: 9014297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.